PPARD and metabolic dysfunction-associated steatotic liver disease: All three PPARs (PPARA, PPARD, and PPARG) were implicated as promoters to increase APOA1 secretion and expression from the liver [16–18], which may partially decode the role of PPARs in NAFLD.